Shares of Edwards Lifesciences Corp. /zigman2/quotes/205745196/composite EW +0.52% inched 0.76% higher to $121.99 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.37% falling 0.34% to 4,520.03 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.43% falling 0.76% to 35,100.00. This was the stock's fourth consecutive day of gains. Edwards Lifesciences Corp. hit a new 52-week high, surpassing its previous peak of $121.37, which the company achieved on September 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Medtronic PLC /zigman2/quotes/206816578/composite MDT -0.34% fell 0.04% to $134.57, Boston Scientific Corp. /zigman2/quotes/203726728/composite BSX +0.77% rose 0.40% to $45.10, and ICU Medical Inc. /zigman2/quotes/208026181/composite ICUI +1.20% rose 1.58% to $205.98. Trading volume (1.9 M) remained 259,139 below its 50-day average volume of 2.2 M.